Next 10 |
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...
2024-05-31 08:59:45 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTe...
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stoc...
SINGAPORE, May 22, 2024 (GLOBE NEWSWIRE) -- AI-Media, world leaders in AI-powered captioning solutions, announces its participation in the Broadcast Asia Expo 2024, held from May 29th to 31st at the Singapore Expo. At Booth #5L3-3, AI-Media will unveil its latest advancements in broadcast caption...
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for th...
2024-05-16 11:52:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AIM ImmunoTech (NYSEMKT: AIM ) just reported results for the first quarter of 2024. AIM ImmunoTech reported earnings per share of -12 cents. This was below the analyst est...
2024-05-16 11:24:09 ET AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Conference Call May 16, 2024 08:30 AM ET Company Participants Thomas Equels - CEO Christopher McAleer - Scientific Officer Conference Call Participants James Molloy - Alliance Global Partne...
2024-05-16 07:33:17 ET More on AIM ImmunoTech AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTech Financial information for AIM ImmunoTech Read ...
Continued execution across Ampligen ® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stoc...